Medical Evidence


One of the earliest and most profound insights into the pathophysiology of COVID-19 disease was that of it’s extreme “hypercoagulability” found the most severely ill patients suffering severe inflammation. The studies below detail both the high incidences and types of clotting complications seen in critically ill COVOD-19 patients along with studies demonstrating associations between anti-coagulant treatment and improvements in survival.